Trials / Unknown
UnknownNCT04374591
The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia
The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia: A Preliminary Report of Short Term Follow up
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Bicarbonate | Inhalation of Sodium Bicarbonate 8.4% via nebulizer |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2020-11-01
- Completion
- 2020-11-01
- First posted
- 2020-05-05
- Last updated
- 2020-10-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04374591. Inclusion in this directory is not an endorsement.